These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38048279)

  • 1. Impact of lamivudine treatment in late pregnancy on the development of the foetal immune response to hepatitis B virus: a meta-analysis in R with the metafor package.
    Zhao P; Zhao Y; Du M; Chen X; Lu Y
    Trans R Soc Trop Med Hyg; 2024 Apr; 118(4):264-272. PubMed ID: 38048279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus.
    Ugwu EO; Eleje GU; Ugwu AO; Nwagha UI; Ikechebelu JI; Umeh UA; Okafor HU
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013653. PubMed ID: 37306558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus.
    Han L; Zhang HW; Xie JX; Zhang Q; Wang HY; Cao GW
    World J Gastroenterol; 2011 Oct; 17(38):4321-33. PubMed ID: 22090789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamivudine vs placebo or no treatment in preventing the transmission of hepatitis B virus during pregnancy: a systematic review and meta-analysis.
    Zhao P; Qian X; Su C; Yang X; Bai X
    Trans R Soc Trop Med Hyg; 2020 Feb; 114(2):121-130. PubMed ID: 31703121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.
    Mantzoukis K; Rodríguez-Perálvarez M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011645. PubMed ID: 28321877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.
    Eke AC; Eleje GU; Eke UA; Xia Y; Liu J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD008545. PubMed ID: 28188612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis.
    Shi Z; Yang Y; Ma L; Li X; Schreiber A
    Obstet Gynecol; 2010 Jul; 116(1):147-159. PubMed ID: 20567182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.
    Xu WM; Cui YT; Wang L; Yang H; Liang ZQ; Li XM; Zhang SL; Qiao FY; Campbell F; Chang CN; Gardner S; Atkins M
    J Viral Hepat; 2009 Feb; 16(2):94-103. PubMed ID: 19175878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting.
    Duri K; Munjoma PT; Mataramvura H; Mazhandu AJ; Chandiwana P; Marere T; Gumbo FZ; Mazengera LR
    BMC Infect Dis; 2023 Oct; 23(1):736. PubMed ID: 37891471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Maternal-fetal outcomes of lamivudine treatment administered during late pregnancy to highly viremic mothers with HBeAg+ chronic hepatitis B].
    Jiang HX; Han GR; Wang CM; Ji Y
    Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):888-91. PubMed ID: 23522247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
    Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus.
    Yu MM; Jiang Q; Ji Y; Wu KH; Ju LL; Tang X; Yang YF
    J Clin Virol; 2014 Sep; 61(1):55-60. PubMed ID: 24994007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis.
    Funk AL; Lu Y; Yoshida K; Zhao T; Boucheron P; van Holten J; Chou R; Bulterys M; Shimakawa Y
    Lancet Infect Dis; 2021 Jan; 21(1):70-84. PubMed ID: 32805200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short article: Hepatitis B virus status in children born to HIV/HBV coinfected women in a French hospital: a cross-sectional study.
    Sellier PO; Schnepf N; Amarsy R; Maylin S; Lopes A; Mazeron MC; Flateau C; Morgand M; Ciraru-Vigneron N; Berthe A; Simoneau G; Evans J; Souak S; Matheron S; Benifla JL; Simon F; Bergmann JF
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):328-32. PubMed ID: 26709883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis.
    Brown RS; McMahon BJ; Lok AS; Wong JB; Ahmed AT; Mouchli MA; Wang Z; Prokop LJ; Murad MH; Mohammed K
    Hepatology; 2016 Jan; 63(1):319-33. PubMed ID: 26565396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Nucleotide/Nucleoside Analogues and Hepatitis B Immunoglobulin Therapy in Blocking Mother-to-Child Transmission of Hepatitis B in an Eastern Chinese Group.
    Sun X; Wang C; Wang B; Yang X; Xu H; Shen M; Zhu K
    Infect Dis Obstet Gynecol; 2020; 2020():4305950. PubMed ID: 33380780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virological responses to tenofovir-alafenamide-containing antiretroviral therapy in people living with HIV co-infected with lamivudine-resistant or lamivudine-susceptible hepatitis B virus.
    Huang YS; Sun HY; Chang SY; Chuang YC; Su YC; Liu WC; Hung CC
    Int J Antimicrob Agents; 2022; 60(5-6):106682. PubMed ID: 36279976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the Efficacy and Safety of Treating Chronic Hepatitis B Infection during Pregnancy with Lamivudine, Telbivudine, and Tenofovir: A Meta-analysis.
    Sali S; Darvishi M; GhasemiAdl M; Akhlaghdoust M; Mirzazadeh A; Behjati SE; Sheikh-Zeinolabedini H; Shokouhi S; Tavakolpour S
    J Clin Transl Hepatol; 2019 Sep; 7(3):197-212. PubMed ID: 31608211
    [No Abstract]   [Full Text] [Related]  

  • 20. Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study.
    Wu Q; Huang H; Sun X; Pan M; He Y; Tan S; Zeng Y; Li L; Deng G; Yan Z; He D; Li J; Wang Y
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1170-6. PubMed ID: 25251571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.